These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17218236)

  • 1. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
    Fulop T; Rákóczi I; Barna I
    J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
    Gallinat A
    J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
    Sabbah R; Desaulniers G
    J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
    Glasser MH; Heinlein PK; Hung YY
    J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
    Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
    BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
    Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
    J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
    Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
    J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miscellaneous uterine malignant neoplasms detected during hysteroscopic surgery.
    Vilos GA; Edris F; Abu-Rafea B; Hollett-Caines J; Ettler HC; Al-Mubarak A
    J Minim Invasive Gynecol; 2009; 16(3):318-25. PubMed ID: 19423062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology.
    Rosenbaum SP; Fried M; Munro MG
    J Minim Invasive Gynecol; 2005; 12(2):144-9. PubMed ID: 15904618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term follow-up after endometrial ablation. A questionnaire study on bleedings, hormone treatment and surgery].
    Krogh RA; Lauszus FF; Rasmussen KL
    Ugeskr Laeger; 2009 Aug; 171(34):2371-6. PubMed ID: 19732517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
    Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
    J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation endometrial ablation treatment: Novasure.
    Bongers MY
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation.
    Loffer FD
    J Minim Invasive Gynecol; 2005; 12(3):254-60. PubMed ID: 15922984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect on radiofrequency heat-coagulation endometrial ablation in the treatment of anovulatory dysfunctional uterine bleeding].
    Yin GP; Li J; Zhu TY; Chen M; Yang SJ; Zhao XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):664-8. PubMed ID: 22176990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
    Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
    J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of endometrial ablation.
    Fürst SN; Philipsen T; Joergensen JC
    Acta Obstet Gynecol Scand; 2007; 86(3):334-8. PubMed ID: 17364309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.